Back to results
US 7,064,199 B2Granted
Process for the manufacture of 3-amino-pyrrolidine derivatives
AssigneeBasilea Pharmaceutica AG
InventorsMarc Muller, Milan Soukup
Life of this patent
Estimating the term…
Abstract
The invention is concerned with a process for the manufacture of vinylpyrrolidinone-cephalosporin derivatives from 3-amino-pyrrolidine derivatives of the formula wherein R1 signifies hydrogen or an amino protecting group; Z signifies hydrogen or an amino protecting group; and * represents a center of chirality.
Claims1
A process for producing a vinylpyrrolidinone-cephalosporin derivative of formula A-1
- wherein
- * denotes a center of chirality;
- comprising:
- (a) converting a compound of the formula II
- wherein
- X is a protected hydroxy group;
- Z1 is an amino protecting group;
- and * is as above in the presence of hydroxylamine or an acid addition salt thereof into the N-hydroxy-pyrrolidine derivative of the formula III
- wherein
- Z1 and * have the same meaning as above;
- (b) reducing said N-hydroxy derivative of formula III to the secondary amine derivative of formula IV
- wherein
- Z1 and * have the same meaning as above by hydrogenation with Raney nickel;
- (c) converting said secondary amine of formula IV into a 3-amino pyrrolidine compound of formula I
- wherein
- R1 is an amino protecting group and * is as above;
- by reaction of the 1-amino group of the compound of formula IV with a compound of formula R1X1, in which R1 has the above indicated meaning, and X1 is halogen or a leaving group, and deprotecting the resulting 3-amino group by catalytic hydrogenation;
- (d) reacting said 3-amino-pyrrolidine compound of formula I with 2-bromo-4-chlorobutanoylchloride to yield a compound of formula (1)
- wherein
- R1 and * have the above indicated meaning
- (e) converting said compound of formula (1) into the corresponding triphenylphosphine Wittig salt of formula (2)
- wherein
- Ph is phenyl and R1 and * are as above;
- (f) reacting said Wittig salt of formula (2) with a diprotected 3-ene cephalosporin derivative of formula (3)
- wherein
- BOC is tert.-butoxycarbonyl;
- and
- Ph is phenyl;
- to yield the condensation product (4)
- wherein *, BOC, R1 and Ph are as above
- (g) oxidizing said condensation product of formula (4) to produce the 5-sulfoxide compound of formula (5)
- wherein *, R1, BOC and Ph are as above.
- (h) reducing the sulfoxide group on said 5-sulfoxide compound of formula (5) to form the 2-ene celphalosporin derivative of formula (6)
- wherein *, BOC and Ph are as above.
- (i) deprotecting the 7-amino group of said compound of formula (6) and acylating the deprotected compound of formula (6) with (Z)-(5-amino[1,2,4]thiadiazol-3-yl-trityloximino-thioacetic acid S-benzothiazol-2-yl ester to yield the compound of formula (1)
- wherein *, R1, Y and Ph are as above;
- and
- (j) removing the protecting amino protecting groups R1 and CPh3 from the compound of formula (9) to produce the compound of formula A-1.
35 more elements
Dependencies are inferred from the claim text.